Plasmonic photothermal release of docetaxel by gold nanoparticles incorporated onto halloysite nanotubes with conjugated 2D8-E3 antibodies for selective cancer therapy
Abstract Background Applied nanomaterials in targeted drug delivery have received increased attention due to tangible advantages, including enhanced cell adhesion and internalization, controlled targeted release, convenient detection in the body, enhanced biodegradation, etc. Furthermore, conjugatio...
Main Authors: | Reza Taheri-Ledari, Wenjie Zhang, Maral Radmanesh, Nicole Cathcart, Ali Maleki, Vladimir Kitaev |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-021-00982-6 |
Similar Items
-
Antibody‐Drug Conjugates to Treat Bacterial Biofilms via Targeting and Extracellular Drug Release
by: Anne Tvilum, et al.
Published: (2023-08-01) -
Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations
by: Yosi Gilad, et al.
Published: (2021-02-01) -
Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy
by: Jakob Lindberg, et al.
Published: (2021-10-01) -
Targeted drug conjugate systems for ovarian cancer chemotherapy
by: Omotola D. Ogundipe, et al.
Published: (2023-09-01) -
Gemcitabine Peptide-Based Conjugates and Their Application in Targeted Tumor Therapy
by: Aleksandra Hawryłkiewicz, et al.
Published: (2021-01-01)